D
Apogee Therapeutics, Inc. APGE
$39.94 $1.614.20%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 99.38% 124.18% 200.43% 305.92% 680.68%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 133.19% 144.90% 143.90% 183.06% 218.34%
Operating Income -133.19% -144.90% -143.90% -183.06% -218.34%
Income Before Tax -116.86% -109.90% -72.49% -100.60% -114.81%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -116.88% -109.90% -72.49% -100.60% -114.81%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -116.88% -109.90% -72.49% -100.60% -114.81%
EBIT -133.19% -144.90% -143.90% -183.06% -218.34%
EBITDA -- -- -- -- --
EPS Basic 56.00% 72.74% 87.42% 66.68% 47.71%
Normalized Basic EPS 56.00% 72.74% 87.41% 66.68% 47.71%
EPS Diluted 56.00% 72.74% 87.42% 66.68% 47.71%
Normalized Diluted EPS 56.00% 72.74% 87.41% 66.68% 47.71%
Average Basic Shares Outstanding 121.58% 274.83% 1,029.79% 962.67% 1,054.74%
Average Diluted Shares Outstanding 121.58% 274.83% 1,029.79% 962.67% 1,054.74%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings